Skip to main content

SOLUCIONES A MEDIDA DEL PACIENTE PARA EL CONTROL DE GLUCOSA EN SANGRE EN DIABETES TIPO 1

PID2019-107722RB-C21

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 26
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Glucose Responses to Aerobic Exercise Are Influenced by Glucose Levels before the Exercise and Menstrual Cycle Phase in Adults with Type 1 Diabetes on Multiple Daily Insulin Injections

  • Cossu, Luca
  • Rossetti, Paolo
  • Martin, Rodrigo Agustin San
  • Ampudia-Blasco, Francisco Javier
  • Facchinetti, Andrea
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Aims: This study aimed to evaluate how pre-exercise glucose levels and menstrual cycle phase influence glucose responses to aerobic exercise in adults with type 1 diabetes (T1D) treated with multiple daily insulin injections, with the goal of improving personalized exercise management.Materials and Methods: We analyzed 51 moderate-intensity, 30-min aerobic sessions (17 male, 34 female) from the TAILOR/1a study. Glucose (plasma and interstitial), heart rate, and anthropometric data were collected. Female participants performed sessions in both the follicular and luteal phases. Glucose trends during exercise were clustered using k-medoids and Dynamic Time Warping. Features from clinical, glucose, and heart rate data were extracted and correlated with cluster assignment.Results: Two distinct glucose response patterns emerged: descending and stable. Higher pre-exercise glucose levels were associated with greater glucose decline and increased hypoglycemia risk, particularly in men. Female participants more frequently exhibited stable glucose profiles, particularly during the luteal phase. Fitness and body composition influenced cluster assignment: fitter individuals-particularly women-were more likely to exhibit stable glucose trends. Pre-exercise glucose was the strongest predictor of response. The menstrual cycle phase had a modest but noticeable effect on glucose dynamics.Conclusions: Glucose response to exercise in T1D is highly variable and influenced by pre-exercise glycemia, sex, fitness level, and menstrual cycle phase. Women, particularly during the luteal phase, demonstrated more stable glycemic responses. These findings support the need for individualized exercise recommendations and for integrating physiological and behavioral factors into predictive models for automated insulin dosing and exercise guidance in T1D., This work received support from Grants PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033 and Grant PID2022-137723OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF/EU."
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Assessment of Seasonal Stochastic Local Models for Glucose Prediction without Meal Size Information under Free-Living Conditions

  • Prendin, Francesco
  • Del Favero, Simone
  • Sparacino, Giovanni
  • Facchinetti, Andrea
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Accurate blood glucose (BG) forecasting is key in diabetes management, as it allows preventive actions to mitigate harmful hypoglycemic/hyperglycemic episodes. Considering the encouraging results obtained by seasonal stochastic models in proof-of-concept studies, this work assesses the methodology in two datasets (open-loop and closed-loop) recorded in free-living conditions. First, similar postprandial glycemic profiles are grouped together with fuzzy C-means clustering. Then, a seasonal stochastic model is identified for each cluster. Finally, real-time BG forecasting is performed by weighting each model's prediction. The proposed methodology (named C-SARIMA) is compared to other linear and nonlinear black-box methods: autoregressive integrated moving average (ARIMA), its variant with input (ARIMAX), a feed-forward neural network (NN), and its modified version (NN-X) fed by BG, insulin, and carbohydrates (timing and dosing) information for several prediction horizons (PHs). In the open-loop dataset, C-SARIMA grants a median root-mean-squared error (RMSE) of 20.13 mg/dL (PH = 30) and 27.23 mg/dL (PH = 45), not significantly different from ARIMA and NN. Over a longer PH, C-SARIMA achieves an RMSE = 31.96 mg/dL (PH = 60) and RMSE = 33.91 mg/dL (PH = 75), significantly outperforming the ARIMA and NN, without significant differences from the ARIMAX for PH >= 45 and the NN-X for PH >= 60. Similar results hold on the closed-loop dataset: for PH = 30 and 45 min, the C-SARIMA achieves an RMSE = 21.63 mg/dL and RMSE = 29.67 mg/dL, not significantly different from the ARIMA and NN. On longer PH, the C-SARIMA outperforms the ARIMA for PH > 45 and the NN for PH > 60 without significant differences from the ARIMAX for PH >= 45. Although using less input information, the C-SARIMA achieves similar performance to other prediction methods such as the ARIMAX and NN-X and outperforming the CGM-only approaches on PH > 45min., This work was partially supported by the project "A noninvasive tattoo-based continuous GLUCOse Monitoring electronic system FOR Type-1 diabetes individuals (GLUCOMFORT)" (initiative "PRIN: Progetti di Rilevante Interesse Nazionale", call 2020, project ID: 2020X7XX2P) and through the initiative "Departments of Excellence" (Law 232/2016); Grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe", Grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033, and the mobility Grant PRX19/00463 funded by MCIN/AEI/10.13039/501100011033 for a research stay of J. Bondia at the University of Padova.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A model of subcutaneous pramlintide pharmacokinetics and its effect on gastric emptying: Proof-of-concept based on populational data

  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Pramlintide, an amylin analog, has been coming up as an agent in type 1 diabetes dual-hormone therapies (insulin/pramlintide). Since pramlintide slows down gastric emptying, it allows for easing glucose control and reducing the burden of meal announcements. Pre-clinical in silico evaluations are a key step in the development of any closed-loop strategy. However, mathematical models are needed, and pramlintide models in the literature are scarce. This work proposes a proof-of-concept pramlintide model, describing its subcutaneous pharmacokinetics (PK) and its effect on gastric emptying (PD). The model is validated with published populational (clinical) data. The model development is divided into three stages: intravenous PK, subcutaneous PK, and PD modeling. In each stage, a set of model structures are proposed, and their performance is assessed using the Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC). In order to evaluate the modulation of the rate of gastric emptying, a literature meal model was used. The final pramlintide model comprises four compartments and a function that modulates gastric emptying depending on plasma pramlintide. Results show an appropriate fit for the data. Some aspects are left as open questions due to the lack of specific data (e.g., the influence of meal composition on the pramlintide effect). Moreover, further validation with individual data is necessary to propose a virtual cohort of patients., This work was partially supported by: grant FPU17/03404 and PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011 033, grant CIPROM/2021/012 funded by Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Accuracy of FreeStyle Libre 3 During Moderate-Intensity Continuous Aerobic Exercise at Different Phases of the Menstrual Cycle in Females with Type 1 Diabetes

  • Cuerda del Pino, Alba
  • Laguna Sanz, Alejandro José
  • Díez, José-Luís
  • Rossetti, Paolo
  • Romero, Cynthia Marco
  • Ampudia-Blasco, F. Javier
  • Martín-San Agustín, Rodrigo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: The use of continuous glucose monitoring (CGM) devices in managing type 1 diabetes (T1D) has been associated with improved glycemic control in individuals with T1D. A key challenge for CGMs, however, is achieving accuracy, particularly under conditions where glucose levels may fluctuate rapidly, such as during exercise. Another factor contributing to blood glucose variability is the menstrual cycle, during which hormonal fluctuations affect insulin sensitivity, leading to variable glucose levels. This study aimed to assess the accuracy of FreeStyle Libre-3 (FSL3) during continuous moderate-intensity aerobic exercise (CONT) performed in the follicular and luteal phases of the menstrual cycle in females with T1D.Methods: Participants underwent CONT sessions on a cycle ergometer, one in the follicular phase and one in the luteal phase of the menstrual cycle, at the Research Laboratory of the Faculty of Physiotherapy. Glucose levels were measured every 10 min using FSL3 and the YSI 2500 as a gold standard. Measurements began 20 min before CONT and continued for 20 min after exercise.Results: A total of 26 females (mean age 32.2 +/- 6.1 years and mean duration of diabetes 16.4 +/- 8.4 years) participated in this study. FSL3 showed significant differences compared with YSI glucose data for both phases of the menstrual cycle (about 16 mg/dL higher in FSL3). There were no differences in mean absolute relative differences (MARDs) between the follicular (16.06%) and luteal (16.43) phases. Moreover, exercise did not affect MARDs, which were 14.21% pre-exercise and 17.63% postexercise for the follicular phase and 14.95% pre-exercise and 17.71% postexercise for the luteal phase.Conclusions: The findings suggest that the accuracy of FSL3 is not affected by CONT, showing good accuracy levels in both phases of the menstrual cycle. Thus, this study is the first to examine the influence of the menstrual cycle and exercise on the accuracy of a CGM device.The study was also prospectively registered at clinicaltrials.gov (NCT06086067)., This work received support from grants PID2019-107722RB-C21 and PID2022-137723OB-C21 funded by MCIN/AEI/10.13039/501100011033 and CIBER (Consorcio Centro de Investigacion Biomedica en Red), group number CB17/08/00004, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, and from the European Union-European Regional Development Fund. Cuerda-del Pino is supported by the University Teaching Training Program (FPU) of the Ministry of Science, Innovation and Universities of Spain. Grant number: FPU20/07337.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

GLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review

  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Glucagon-like peptide 1 (GLP-1) is a hormone that promotes insulin secretion, delays gastric emptying, and inhibits glucagon secretion. The GLP-1 receptor agonists have been developed as adjunctive therapies for type 2 diabetes to improve glucose control. Recently, there has been an interest in introducing GLP-1 receptor agonists as adjunctive therapies in type 1 diabetes alongside automatic insulin delivery systems. The preclinical validation of these systems often relies on mathematical simulators that replicate the glucose dynamics of a person with diabetes. This review aims to explore mathematical models available in the literature to describe GLP-1 effects to be used in a type 1 diabetes simulator. Methods: Three databases were examined in the search for GLP-1 mathematical models. More than 1500 works were found after searching for specific keywords that were narrowed down to 39 works for full-text assessment. Results: A total of 23 works were selected describing GLP-1 pharmacokinetics and pharmacodynamics. However, none of the found models was designed for type 1 diabetes. An analysis is included of the available models¿ features that could be translated into a GLP-1 receptor agonist model for type 1 diabetes. Conclusion: There is a gap in research in GLP-1 receptor agonists mathematical models for type 1 diabetes, which could be incorporated into type 1 diabetes simulators, providing a safe and inexpensive tool to carry out preclinical validations using these therapies., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partially supported by PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033 and grant CIPROM/2021/012 funded by Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

On the Use of Population Data for Training Seasonal Local Models-Based Glucose Predictors: An In Silico Study

  • Aslan, Antonio
  • Laguna Sanz, Alejandro José
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Most advanced technologies for the treatment of type 1 diabetes, such as sensor-pump integrated systems or the artificial pancreas, require accurate glucose predictions on a given future time-horizon as a basis for decision-making support systems. Seasonal stochastic models are data-driven algebraic models that use recent history data and periodic trends to accurately estimate time series data, such as glucose concentration in diabetes. These models have been proven to be a good option to provide accurate blood glucose predictions under free-living conditions. These models can cope with patient variability under variable-length time-stamped daily events in supervision and control applications. However, the seasonal-models-based framework usually needs of several months of data per patient to be fed into the system to adequately train a personalized glucose predictor for each patient. In this work, an in silico analysis of the accuracy of prediction is presented, considering the effect of training a glucose predictor with data from a cohort of patients (population) instead of data from a single patient (individual). Feasibility of population data as an input to the model is asserted, and the effect of the dataset size in the determination of the minimum amount of data for a valid training of the models is studied. Results show that glucose predictors trained with population data can provide predictions of similar magnitude as those trained with individualized data. Overall median root mean squared error (RMSE) (including 25% and 75% percentiles) for the predictor trained with population data are {6.96[4.87,8.67], 12.49[7.96,14.23], 19.52[10.62,23.37], 28.79[12.96,34.57], 32.3[16.20,41.59], 28.8[15.13,37.18]} mg/dL, for prediction horizons (PH) of {15,30,60,120,180,240} min, respectively, while the baseline of the individually trained RMSE results are {6.37[5.07,6.70], 11.27[8.35,12.65], 17.44[11.08,20.93], 22.72[14.29,28.19], 28.45[14.79,34.38], 25.58[13.10,36.60]} mg/dL, both training with 16 weeks of data. Results also show that the use of the population approach reduces the required training data by half, without losing any prediction capability., This work was supported by grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033, by grant CIPROM/2021/012 funded by Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana, by CIBER -Consorcio Centro de Investigacion Biomedica en Redgroup number CB17/08/00004, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion and by European Union-European Regional Development Fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems

  • Sala-Mira, Iván|||0000-0002-6228-5190
  • García Gil, Pedro José|||0000-0002-1202-1269
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background and Objectives Hybrid artificial pancreas systems outperform current insulin pump therapies in blood glucose regulation in type 1 diabetes. However, subjects still have to inform the system about meals intake and exercise to achieve reasonable control. These patient announcements may result in overburden and compromise controller performance if not provided timely and accurately. Here, a hybrid artificial pancreas is extended with an add-on module that releases subjects from meals and exercise announcements. Methods The add-on module consists of an internal-model controller that generates a ¿virtual¿ control action to compensate for disturbances. This ¿virtual¿ action is converted into insulin delivery, rescue carbohydrates suggestions, or insulin-on-board limitations, depending on a switching logic based on glucose measurements and predictions. The controller parameters are tuned by optimization and then related to standard parameters from the open-loop therapy. This module is implemented in a hybrid artificial pancreas system proposed by our research group for validation. This hybrid system extended with the add-on module is compared with the hybrid controller with carbohydrate counting errors (hybrid) and the hybrid controller with an alternative unannounced meal compensation module based on a meal detection algorithm (meal detector). The validation used the educational version of the UVa/Padova simulator to simulate the three controllers under two scenarios: one with only meals and another with meals and exercise. The exercise was modeled as a temporal increase of the insulin sensitivity resulting in the glucose drop usually related to an aerobic exercise. Results For the scenario with only meals, the three controllers achieved similar time in range (proposed: 85.1 [77.9,88.1]%, hybrid: 84.0 [75.9,86.4]%, meal detector: 81.9 [79.3,83.8]%, median [interquartile range]) with low time in moderate hypoglycemia. Under the scenario with meals and exercise, the proposed module reduces 4.61% the time in hypoglycemia achieved with the other controllers, suggesting an acceptable amount of rescues (27.2 [23.7, 31.0] g). Conclusions The proposed add-on module achieved promising results: it outperformed the meal-detector-based controller, even achieving a postprandial performance as good as the hybrid controller (with carbohydrate counting errors). Also, the rescue suggestion feature of the module mitigated exercise-induced hypoglycemia with admissible rescue amounts., This work was partially supported by: grant PID2019-107722RBC21 funded by MCIN/AEI/10.13039/50110 0 011033 and grant ACIF/2017/021 funded by the Generalitat Valenciana through FSE funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Impact of High-Intensity Interval Exercise With Elastic Bands Versus Continuous Moderate-Intensity Aerobic Exercise on Glycemic Control in People With Type 1 Diabetes

  • Martin-San Agustin, Rodrigo
  • Cuerda del Pino, Alba
  • Laguna Sanz, Alejandro José
  • Palanca, Ana
  • Rossetti, Paolo
  • Cynthia Marco Romero
  • Ampudia-Blasco, F. Javier
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Engaging in physical exercise is recommended to enhance cardiovascular health and manage blood sugar levels in people with type 1 diabetes (T1D). Hypothesis: The impact of high-intensity interval exercise with elastic bands (EB-HIIE) versus continuous moderate-intensity aerobic exercise (CONT) on glycemic control is different in men with T1D. Study Design: Crossover study design. Level of Evidence: Level 3. Methods: Participants (39 men with T1D) underwent either an EB-HIIE or a CONT session in randomized order, with a separation of >= 72 hours to avoid carry-over effects. Changes in glucose values during exercise were measured simultaneously from venous blood (YSI) and interstitial fluid (Dexcom G6 glucose sensor). Subsequent 24-hour glucose was monitored using the glucose sensor. Results: Blood glucose was lower in CONT vs EB-HIIE (P < .01). Post hoc analysis revealed clinically relevant differences during exercise (-35.1 mg/dl; P = .02), at its end (-49.5 mg/dl; P < .01), and at 10 and 20 minutes after completion (-51.2 mg/dl; P < .01 and -45.9 mg/dl; P < .01, respectively). Time-in-range 24 hours after exercise completion was significantly higher with EB-HIIE than with CONT (66.5% vs 59.3%), although both were significantly better than the previous 24 hours before exercise (50%). Conclusion: Results suggest that EB-HIIE is a safe training method for male adults with diabetes, resulting in euglycemia during and immediately after exercise and improving glucose outcomes in the subsequent 24 hours. Clinical Relevance: This study provides new evidence and practical information on how to implement safe physical activity in daily life of patients with diabetes. EB-HIIT exhibited lower hypoglycemia risk during exercise and better glycemic control in the subsequent 24 hours. In contrast, practicing CONT exercise is associated with higher risk of hypoglycemia. Healthcare providers should take this information into account when prescribing exercise., The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grant PID2019- 107722RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by CIBER-Consorcio Centro de Investigacion Biomedica en Red- group number CB17/08/00004 and CB07/08/0018, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion and by European Union-European Regional Development Fund. A.P. is a recipient of a Sara Borrell postdoctoral grant from the Instituto de Salud Carlos III (CD22/00012).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Patterns of circulating cytokines after 2 types of exercise in active type-1 diabetic patients

  • Herranz-Lopez, Maria
  • Martin-San Agustin, Rodrigo
  • Olivares-Vicente, Marilo
  • Pardines-Oltra, Laura
  • Cuerda Del Pino, Alba
  • Rossetti, Paolo
  • Ampudia-Blasco, F. Javier
  • Roche, Enrique
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Aerobic training (beneficial for type 1 diabetes mellitus (T1DM) patients) could result boring, leading to inactivity or suboptimal performance. Therefore, High-Intensity Interval Training (HIIT) could be an appealing alternative. The present study aimed to compare modulation of certain inflammatory cytokines in T1DM participants performing aerobic vs. HIIT routines. We recruited 26 T1DM male subjects: ages 18-40, T1DM >= 2 years, glycated hemoglobin < 8.5%, stable insulin regimen for 6 months, minimum 90 min weekly physical activity and completion of International Physical Activity Questionnaire (IPAQ). IPAQ:2 corresponds to moderate activity and IPAQ:3 to intense physical activity. Participants performed a single aerobic or HIIT session separated by at least 72 h. Blood plasma samples were collected 20 min before and after each session. Cytokines were measured using LUMINEX technique. After aerobic exercise, pro-inflammatory cytokines interleukin (IL)-1 beta, IL-6, IL-7, IL-8, IL-17 A, tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) showed no significant differences in participants (IPAQ:2 and 3). Only anti-inflammatory cytokine IL-2 increased significantly in IPAQ:3 participants. Compared to pre-exercise, post-exercise HIIT situation presented a similar pattern. The 4 participants (IPAQ:3) that voluntarily followed a 12-week HIIT routine, showed significant increases in IL-7, IL-8, and TNF- alpha, and the detection of the anti-inflammatory cytokine IL-22. Altogether, these results suggest that HIIT favors the presence of some pro-inflammatory cytokines. The anti-inflammatory action of certain cytokines, such as IL-22, should be considered for a possible compensatory action. Nevertheless, programs of interval exercises at moderate intensity could be at the moment a safe option for T1DM patients. Key Points circle Significant increase was observed only for IL-2 after aerobic exercise in participants of IPAQ:3 level. circle Pro-inflammatory cytokine levels do not change significantly after aerobic or HIIT routines, except for IL-6, IL-7 and IL-8 at long-term in participants of IPAQ:3 level. circle Anti-inflammatory cytokines IL-2 (short-term) and IL-22 (long-term) show significant changes after aerobic and HIIT exercises in participants of IPAQ:3 level., This work was supported by CIBER (CB12/03/30038, Physiopathology of Obesity and Nutrition, CIBERobn, Instituto de Salud Carlos III), by grant PID2019-107722RBC21 funded by MCIN/AEI/10.13039/501100011033, and by grant PROMETEO/2021/059 from the Generalitat Valenciana. M.O.-V. has also been supported by the Margarita Salas modality within the Requalification of the Spanish University System for 2021/2023 grant. Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

In silico evaluation of pramlintide dosing algorithms in artificial pancreas systems

  • Pons-Torres, Borja
  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Sanz Diaz, Ricardo
  • García, Pedro
[EN] Pramlintide¿s capability to delay gastric emptying has motivated its use in artificial pancreas systems, accompanying insulin as a control action. Due to the scarcity of pramlintide simulation models in the literature, in silico testing of insulin-plus-pramlintide strategies is not widely used. This work incorporates a recent pramlintide pharmacokinetics/pharmacodynamics model into the T1DM UVA/Padova simulator to adjust and validate four insulin-plus-pramlintide control algorithms. The proposals are based on an existing insulin controller and administer pramlintide either as independent boluses or as a ratio of the insulin infusion. The results of the insulin-pramlintide algorithms are compared against their insulin-alone counterparts, showing an improvement in the time in range between 3.00% and 10.53%, consistent with results reported in clinical trials in the literature. Future work will focus on individualizing the pramlintide model to the patients¿ characteristics and evaluating the implemented strategies under more challenging scenarios., This work was supported by MCIN/AEI/10.13039/501100011033 under Grant PID2019-107722RB-C21; Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana under Grant CIPROM/2021/012; and Plan de ayudas a la I+D+i del Instituto AI2, Convocatoria 2022.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Modeling the effect of glucagon on endogenous glucose production in type 1 diabetes: On the role of glucagon receptor dynamics

  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Sanz Diaz, Ricardo
  • Ritschel, Tobias K.S.
  • Reenberg, Asbjorn Thode
  • Ranjan, Ajenthen G.
  • Norgaard, Kirsten
  • Jorgensen, John Bagterp
[EN] This paper validates a glucoregulatory model including glucagon receptors dynamics in the description of endogenous glucose production (EGP). A set of models from literature are selected for a head-to-head comparison in order to evaluate the role of glucagon receptors. Each EGP model is incorporated into an existing glucoregulatory model and validated using a set of clinical data, where both insulin and glucagon are administered. The parameters of each EGP model are identified in the same optimization problem, minimizing the root mean square error (RMSE) between the simulation and the clinical data. The results show that the RMSE for the proposed receptors-based EGP model was lower when compared to each of the considered models (Receptors approach: 7.13 ± 1.71 mg/dl vs. 7.76 ± 1.45 mg/dl (¿ = 0.066), 8.45 ± 1.38 mg/dl (¿ = 0.011) and 8.99 ± 1.62 mg/dl (¿ = 0.007)). This raises the possibility of considering glucagon receptors dynamics in type 1 diabetes simulators., This work was supported by grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; C.F.N. received grant FPU17/03404 funded by MCIN/AEI/10.1303 9/501100011033 and "ERDF A way of making Europe"; grant CIPROM/2021/12 funded by Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana; A.G.R. received a postdoctoral fellowship from the Danish Diabetes Academy (PD002-19) supported by the Novo Nordisk Foundation and received a research grant from the Danish Diabetes Association; K. N. affiliation to Steno Diabetes Center Copenhagen is public funded by The Capital Region.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Comprehensive Review of Continuous Glucose Monitoring Accuracy during Exercise Periods

  • Muñoz Fabra, Elena
  • Laguna Sanz, Alejandro José
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous Glucose Monitoring (CGM) has been a springboard of new diabetes management technologies such as integrated sensor-pump systems, the artificial pancreas, and more recently, smart pens. It also allows patients to make better informed decisions compared to a few measurements per day from a glucometer. However, CGM accuracy is reportedly affected during exercise periods, which can impact the effectiveness of CGM-based treatments. In this review, several studies that used CGM during exercise periods are scrutinized. An extensive literature review of clinical trials including exercise and CGM in type 1 diabetes was conducted. The gathered data were critically analysed, especially the Mean Absolute Relative Difference (MARD), as the main metric of glucose accuracy. Most papers did not provide accuracy metrics that differentiated between exercise and rest (non-exercise) periods, which hindered comparative data analysis. Nevertheless, the statistic results confirmed that CGM during exercise periods is less accurate., This work was supported by the Ministerio de Economía, Industria y Competitividad (MINECO), Grant Number DPI2016-78831-C2-1-R, the Agencia Estatal de Investigación PID2019-107722RB-C21 / AEI /10.13039/501100011033, the European Union (FEDER funds), and the Vicerectorate of Research, Innovation and Technology Transference from the Universitat Politècnica de València (Grant Number PAID-06-18).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Contributions to Glucagon and Pramlintide Pharmacokinetics and Pharmacodynamics Modeling for Multi-Hormone Artificial Pancreas Systems

  • Furió-Novejarque, Clara|||0000-0003-2923-6618
[ES] La regulación de los niveles de glucosa en el cuerpo humano es el resultado de la secreción coordinada de hormonas. La Diabetes Tipo 1 (DT1) es una enfermedad crónica que provoca la destrucción de las células responsables de la producción de insulina, uno de los principales agentes en la regulación de glucosa. Por tanto, las personas con DT1 dependen de la administración exógena de insulina. No obstante, la gestión de la terapia no es sencilla y está sujeta a una gran variabilidad. Los sistemas de Páncreas Artificial se diseñaron con el objetivo de simplificar la gestión de la enfermedad, administrando insulina de manera automática a través de una bomba de insulina, en base a la lógica de un algoritmo de control que emplea información de un monitor continuo de glucosa. Sin embargo, la acción de la insulina es unidireccional (disminuye el valor de la glucosa), y a veces resulta insuficiente para mantener unos niveles seguros de glucosa en sangre. Por eso, en ocasiones se administran otras hormonas, con efectos opuestos (como el glucagón), o complementarios (como la pramlintida) a la insulina. Para que los sistemas automáticos se beneficien de estas acciones de control, es necesario estudiar y conocer sus dinámicas para poder simular su comportamiento, diseñar controladores que los tengan en cuenta y realizar experimentos in silico previos a utilizar los sistemas en pacientes. El uso del glucagón ya cuenta con una larga trayectoria y ha sido utilizado en varios sistemas automáticos. Sin embargo, existe mucha heterogeneidad en las formulaciones de modelos del efecto del glucagón, sobre todo en relación con su interacción con la insulina, y es necesario profundizar en el desarrollo de modelos que reflejen mejor la fisiología subyacente. Por otra parte, los modelos de pramlintida apenas se han estudiado. El objetivo principal de esta tesis es contribuir a mejorar simuladores para validar sistemas de páncreas artificial. En concreto, se realiza un análisis detallado del estado del arte para conocer las propuestas de modelos fisiológicos en la literatura, para luego centrarse en la descripción del efecto de glucagón en la producción endógena de glucosa y la farmacocinética y farmacodinámica de la pramlintida. El trabajo incluye la propuesta de nuevos modelos para glucagón y pramlintida basados en la fisiología, validados con datos clínicos individuales en el caso del glucagón y con datos poblacionales de la literatura en el caso de la pramlintida, mejorando en ambos casos los resultados previamente existentes., [CA] La regulació dels nivells de glucosa en el cos humà és el resultat de la secreció coordinada d'hormones. La Diabetis Tipus 1 (DT1) és una malaltia crònica que provoca la destrucció de les cèl·lules responsables de la producció d'insulina, un dels principals agents en la regulació de glucosa. Per tant, les persones amb DT1 depenen de l'administració exògena d'insulina. No obstant això, la gestió de la teràpia no és senzilla i està subjecta a una gran variabilitat. Els sistemes de Pàncrees Artificial es van dissenyar amb l'objectiu de simplificar la gestió de la malaltia, administrant insulina de manera automàtica a través d'una bomba d'insulina, en funció de la lògica d'un algorisme de control que empra informació d'un monitor continu de glucosa. No obstant això, l'acció de la insulina és unidireccional (disminueix el valor de la glucosa), i de vegades resulta insuficient per a mantindre uns nivells segurs de glucosa en sang. Per això, ocasionalment s'administren altres hormones, amb efectes oposats (com el glucagó), o complementaris (com la pramlintida) a la insulina. Perquè els sistemes automàtics es beneficien d'aquestes accions de control, és necessari estudiar i conéixer les seues dinàmiques per a poder simular el seu comportament, dissenyar controladors que els tinguen en compte i realitzar experiments in silico previs a utilitzar els sistemes en pacients. L'ús del glucagó ja compta amb una llarga trajectòria i ha sigut utilitzat en diversos sistemes automàtics. No obstant això, existeix molta heterogeneïtat en les formulacions de models de l'efecte del glucagó, sobretot en relació amb la seua interacció amb la insulina, i és necessari aprofundir en el desenvolupament de models que reflectisquen millor la fisiologia subjacent. D'altra banda, els models de pramlintida a penes s'han estudiat. L'objectiu principal d'aquesta tesi és contribuir a millorar simuladors per a validar sistemes de pàncrees artificial. En concret, es fa una anàlisi detallada de l'estat de l'art per a conéixer les propostes de models fisiològics en la literatura, per a després centrar-se en la descripció de l'efecte de glucagó en la producció endògena de glucosa i la farmacocinètica i farmacodinàmica de la pramlintida. El treball inclou la proposta de nous models per a glucagó i pramlintida basats en la fisiologia, validats amb dades clíniques individuals en el cas del glucagó i amb dades poblacionals de la literatura en el cas de la pramlintida, millorant en tots dos casos els resultats prèviament existents., [EN] Glucose regulation in the human body results from the coordinated secretion of hormones. Type 1 Diabetes (T1D) is a chronic disease that destroys insulin-producing cells, one of the main agents in the glucose regulation process. Consequently, people with T1D depend on exogenous insulin administration. However, therapy management is not an easy task, and it faces great variability. Artificial Pancreas systems were designed to ease the disease management, administering insulin automatically through an insulin pump based on the logic of a control algorithm that reads information from a continuous glucose monitor. Nevertheless, insulin action is uni-directional (lowering glucose values), and sometimes, it is insufficient to maintain safe plasma glucose levels. That is why, occasionally, other hormones are also administered, with opposite (like glucagon) or complementary effects (like pramlintide) to insulin. For automatic systems to benefit from these control actions, it is necessary to study and know their dynamics to simulate their behavior, design aware controllers, and carry out in silico experiments before using the system with patients. Glucagon use in T1D has a long trajectory; and has been used in automatic systems. However, there exists a wide heterogeneity in the definitions of glucagon effect, especially related to its interaction with insulin, and it is necessary to develop models that are more physiologically accurate. On the other hand, pramlintide models have barely been studied. This thesis' main objective is to improve T1D simulators to validate artificial pancreas systems. Specifically, a detailed analysis of the state of the art is carried out to know the physiological model proposals in the literature. Then, the focus moves to describing the glucagon effect on endogenous glucose production and the pharmacokinetics and pharmacodynamics of pramlintide. This work includes the proposal of new physiology-based models for glucagon and pramlintide. The glucagon model was validated with individual clinical data, and the pramlintide model was validated with populational data. Both proposals improved previously existing results., This work was supported by grant FPU17/03404, grant EST19/00740, and project PID2019-107722RB-C21, funded by MCIN/AEI/10.13039/501100011033.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Super-twisting-based meal detector for type 1 diabetes management: Improvement and assessment in a real-life scenario

  • Faccioli, S.
  • Facchinetti, A.
  • Sparacino, G.
  • del Favero, S.
  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to improve postprandial control in type 1 diabetes. However, this is an extra burden on subjects, and it introduces a source of potential errors that could impact control performances. In fact, carbohydrates estimation is challenging, prone to errors, and it is known that subjects sometimes struggle to adhere to this requirement, forgetting to perform this task. A possible solution is the use of automated meal detection algorithms. In this work, we extended a super-twisting-based meal detector suggested in the literature and assessed it on real-life data. Methods: To reduce the false detections in the original meal detector, we implemented an implicit discretization of the super-twisting and replaced the Euler approximation of the glucose derivative with a Kalman filter. The modified meal detector is retrospectively evaluated in a challenging real-life dataset corresponding to a 2-week trial with 30 subjects using sensor-augmented pump control. The assessment includes an analysis of the nature and riskiness of false detections. Results: The proposed algorithm achieved a recall of 70 [13] % (median [interquartile range]), a precision of 73 [26] %, and had 1.4 [1.4] false positives-per-day. False positives were related to rising glucose conditions, whereas false negatives occurred after calibrations, missing samples, or hypoglycemia treatments. Conclusions: The proposed algorithm achieves encouraging performance. Although false positives and false negatives were not avoided, they are related to situations with a low risk of hypoglycemia and hyperglycemia, respectively., This work was supported by grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"; grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; the Generalitat Valenciana through FSE funds (grant number ACIF/2017/021); the Italian Ministry of Education, Universities and Research (MIUR) through the project "Learn4AP: Patient-Specific Models for an Adaptive, Fault Tolerant Artificial Pancreas"(SIR initiative, project ID: RBSI14JYM2); the MIUR under the initiative "Departments of Excellence"(Law 232/2016).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes

  • Cuerda del Pino, Alba
  • Rodrigo Martín-San Agustín
  • Laguna Sanz, Alejandro José
  • Palanca, Ana
  • Rossetti, Paolo
  • Gumbau-Gimenez, Maria
  • Ampudia-Blasco, Francisco Javier
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: This study aimed to evaluate the accuracy of Dexcom G6 (DG6) and FreeStyle Libre-2 (FSL2) during aerobic training and high-intensity interval training (HIIT) in individuals with type 1 diabetes. Methods: Twenty-six males (mean age 29.3 +/- 6.3 years and mean duration of diabetes 14.9 +/- 6.1 years) participated in this study. Interstitial glucose levels were measured using DG6 and FSL2, while plasma glucose levels were measured every 10 min using YSI 2500 as the reference for glucose measurements in this study. The measurements began 20 min before the start of exercise and continued for 20 min after exercise. Seven measurements were taken for each subject and exercise. Results: Both DG6 and FSL2 devices showed significant differences compared to YSI glucose data for both aerobic and HIIT exercises. Continuous glucose monitoring (CGM) devices exhibited superior performance during HIIT than aerobic training, with DG6 showing a mean absolute relative difference of 14.03% versus 31.98%, respectively. In the comparison between the two devices, FSL2 demonstrated significantly higher effectiveness in aerobic training, yet its performance was inferior to DG6 during HIIT. According to the 40/40 criteria, both sensors performed similarly, with marks over 93% for all ranges and both exercises, and above 99% for HIIT and in the >180 mg/dL range, which is in accordance with FDA guidelines. Conclusions: The findings suggest that the accuracy of DG6 and FSL2 deteriorates during and immediately after exercise but remains acceptable for both devices during HIIT. However, accuracy is compromised with DG6 during aerobic exercise. This study is the first to compare the accuracy of two CGMs, DG6, and FSL2, during two exercise modalities, using plasma glucose YSI measurements as the gold standard for comparisons. It was registered at clinicaltrials.gov (NCT06080542)., This work received support from grants PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033 and CIBER (Consorcio Centro de Investigacion Biomedica en Red), group number CB17/08/00004, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, and from the European Union-European Regional Development Fund. AP was additionally supported by a Sara Borrell postdoctoral grant from the Instituto de Salud Carlos III (CD22/00012).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Impact of High Intensity Interval Training Using Elastic Bands on Glycemic Control in Adults with Type 1 Diabetes: A Pilot Study

  • Martín-San Agustín, Rodrigo
  • Laguna Sanz, Alejandro José
  • Roche, Enrique
  • Benítez Martínez, Josep C.
  • Ampudia-Blasco, F. Javier
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] High intensity interval training (HIIT) using elastic bands is easy to do, but no data on its impact on glycemic control in people with type 1 diabetes (T1D) are available. Six males with T1D performed three weekly sessions of HIIT using elastic bands for 12 weeks. Each session consisted of eight exercises. Glycemic control was evaluated by using intermittent scanning continuous glucose monitoring two weeks before study onset (baseline) and during the intervention period in the first two (first stage) and last two weeks (last stage). In the 24 h post-exercise, time-in-range (70-180 mg/dL) was reduced from baseline to the end of the study (67.2% to 63.0%), and time-above-range (>180 mg/dL) seemed to increase from baseline across the study (20.8% -> 27.5% -> 22.1%, from baseline -> first -> last stage), but did not show any statistical significance. Time in hypoglycemia (either < 70 mg/dL or <54 mg/dL) did not show statistically significant differences. This study shows that a HIIT program with elastic bands is safe and effective to perform in T1D patients, keeping blood glucose levels in a safe range., This study was funded by MINECO DPI2016-78831-C2-1-R, Agencia Estatal de Investigacion (PID2019-107722RB-C21/AEI/10.13039/501100011033), FEDER funds from EU, and the Vicerectorate of Research, Innovation and Technology Transference from the Universitat Politecnica de Valencia grant number PAID-06-18. This study was also supported by the official funding agency for biomedical research of the Spanish government, Institute of Health Carlos III (ISCIII) through CIBEROBN CB12/03/30038, and CIBERDEM CB17/08/00004, which is co-funded by the European Regional Development Fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomized crossover trial

  • García, Alia
  • Moscardo-Garcia, Vanessa
  • Ramos-Prol, Agustín
  • Diaz, Julián
  • Boronat, Miguel
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Introduction Meal composition is known to affect glycemic variability and glucose control in type 1 diabetes. The objective of this work was to evaluate the effect of high carbohydrate meals of different nutritional composition and alcohol on the postprandial glucose response in patients with type 1 diabetes. Research design and methods Twelve participants were recruited to this randomized crossover trial. Following a 4-week run-in period, participants received a mixed meal on three occasions with the same carbohydrate content but different macronutrient composition: high protein-high fat with alcohol (0.7g/kg body weight, beer), high protein-high fat without alcohol, and low protein-low fat without alcohol at 2-week intervals. Plasma and interstitial glucose, insulin, glucagon, growth hormone, cortisol, alcohol, free fatty acids, lactate, and pH concentrations were measured during 6 hours. A statistical analysis was then carried out to determine significant differences between studies. Results Significantly higher late postprandial glucose was observed in studies with higher content of fats and proteins (p=0.0088). This was associated with lower time in hypoglycemia as compared with the low protein and fat study (p=0.0179), at least partially due to greater glucagon concentration in the same period (p=0.04). Alcohol significantly increased lactate, decreased pH and growth hormone, and maintained free fatty acids suppressed during the late postprandial phase (p<0.001), without significant changes in plasma glucose. Conclusions Our data suggest that the addition of proteins and fats to carbohydrates increases late postprandial blood glucose. Moreover, alcohol consumption together with a mixed meal has relevant metabolic effects without any increase in the risk of hypoglycemia, at least 6 hours postprandially., This paper presents independent research financially supported by Ministerio de Economia y Competitividad (MINECO) (DPI2016--78831-C2--1--R), Agencia Estatal de Investigacion (PID2019--107722RB--C21/AEI/10.13039/501100011033), and the European Union through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Near-optimal feedback control for postprandial glucose regulation in type 1 diabetes

  • Sanz Diaz, Ricardo
  • García Gil, Pedro José|||0000-0002-1202-1269
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] This paper is focused on feedback control of postprandial glucose levels for patients with type 1 Diabetes Mellitus. There are two important limitations that make this a challenging problem. First, the slow subcutaneous insulin pharmacokinetics that introduces a significant lag into the control loop. Second, the positivity constraint on the control action, meaning that it is not possible to remove insulin from the body. In this paper, both issues are explicitly considered in the design process using the internal model control framework, to derive a near-optimal feedback controller. Optimality is understood here as minimizing the blood glucose peak after a meal intake and, at the same time, preventing glucose values below a prescribed threshold. It is shown how the proposed controller approaches the optimal closed-loop performance as a limit case. The theoretical results are supported by a numerical example and the feasibility of the overall strategy under uncertainties is illustrated using an extended version UVa/Padova metabolic simulator. (c) 2022 Published by Elsevier Ltd on behalf of ISA., This work was partially supported by: grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"; grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; grant PAID-10-19 funded by Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effect of Ethanol Consumption on the Accuracy of a Glucose Oxidase-Based Subcutaneous Glucose Sensor in Subjects with Type 1 Diabetes

  • Moscardó, Vanessa
  • Garcia, Alia
  • Diaz, Julián
  • Ramos-Prol, Agustín
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous glucose monitors (CGM) have improved the management of patients with type 1 diabetes (T1D), with glucose oxidase (GOx)-based sensors being the most used. However, they are potentially subject to both electrochemical and enzymatic interferences, including those related to changes of pH. The objective of this study is to investigate the effect of ethanol, given as beer along with a mixed meal, on the accuracy of a commercial GOx-CGM. Data from 12 T1D participants in a randomized crossover trial to evaluate the effect of meal composition and alcohol consumption on postprandial glucose concentration were used. Absolute error (AE) and mean absolute relative difference (MARD) were calculated. The differences between the alcohol and nonalcohol scenarios were assessed using the Mann-Whitney U and Wilcoxon signed-rank tests. The AE in the alcohol study was low, but significantly greater as compared to the study without alcohol (p-value = 0.0418). The MARD was numerically but not significantly greater. However, both variables were greater at pH < 7.36 and significantly affected by time only in the alcohol arm. In T1D, alcohol consumption affects the accuracy of a GOx-CGM. This effect could be at least partially related to the ethanol-induced changes in pH., This research was funded by grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe"; and grant PID2019-107722RBC21 funded by MCIN/AEI/10.13039/501100011033.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Glucose Prediction under Variable-Length Time-Stamped Daily Events: A Seasonal Stochastic Local Modeling Framework

  • Montaser, Eslam
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Accurate glucose prediction along a long-enough time horizon is a key component for technology to improve type 1 diabetes treatment. Subjects with diabetes might benefit from supervision and control systems that accurately predict risks and trigger corrective actions early enough with improved mitigation. However, large intra-patient variability poses big challenges to glucose prediction. In previous works by the authors, clustering and local modeling techniques with seasonal stochastic models proved to be efficient, allowing for good glucose prediction accuracy for long prediction horizons. Continuous glucose monitoring (CGM) data were partitioned into fixed-length postprandial time subseries and clustered with Fuzzy C-Means to collect similar behaviors, enforcing seasonality at each cluster after subseries concatenation. Then, seasonal stochastic models were identified for each cluster and local predictions were integrated into a global prediction. However, free-living conditions do not support the fixed-length partition of CGM data since daily events duration is variable. In this work, a new algorithm is provided to overcome this constraint, allowing better coping with patient's variability under variable-length time-stamped daily events in supervision and control applications. Besides predicted glucose, two real-time indices are additionally provided-a crispness index, indicating good representation of current glucose behavior by a single model, and a normality index, allowing for the detection of an abnormal glucose behavior (unusual according to registered historical data). The framework is tested in a proof-of-concept in silico study with ten patients over four month training data and two independent two month validation datasets, with and without abnormal behaviors, from the distribution version of the UVA/Padova simulator extended with diverse sources of intra-patient variability., This work was supported by the Ministerio de Economia, Industria y Competitividad (MINECO), Grant Number DPI2016-78831-C2-1-R, the Agencia Estatal de Investigacion PID2019107722RB-C21/AEI/10.13039/501100011033, and the European Union (FEDER funds).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Analysis on the contribution of glucagon receptors to glucose dynamics in type 1 diabetes

  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Ranjan, Ajenthen G.
  • Nørgaard, Kirsten
  • Jørgensen, John Bagterp
[EN] The glucagon effect is understudied in type 1 diabetes (T1D) simulators, without a clear consensus on the pharmacodynamics of glucagon over glucose. Glucagon receptors dynamics could present a significant contribution to T1D simulators, making them more physiologically accurate without an excessive increase in complexity. This work analyzes the receptors model contributions to glucose dynamics using a model proposed in previous work. Then, the model is assessed from two different perspectives: (1) A clinical dataset of the influence of diet (high or low carbohydrate content) on two consecutive glucagon doses (100 and 500 µg) is used to identify the model parameters and (2) three other glucagon action models from the literature are also identified to serve as comparators. Different identification methods are used to adapt to the distinctive features of the dataset. The root mean square error (RMSE) and the Akaike Information Criterion (AIC) were the discerning metrics used to compare the models fittings. Results show that the receptors model offers the lowest RMSE and AIC in contrast to the comparators. This model will hence be helpful in the development of accurate T1D simulators., This work was partially supported by: PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033, and Grant CIPROM/2021/012 funded by Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana, Spain. Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

New Contributions Towards Meal and Exercise Announcement-Free Artificial Pancreas Systems

  • Sala-Mira, Iván|||0000-0002-6228-5190
[ES] Las infusiones exógenas de insulina son vitales para las personas con diabetes tipo 1 para suplir parcialmente la incapacidad del páncreas de secretar insulina. Sin embargo, las terapias intensivas actuales pueden restringir la calidad de vida de los pacientes. Los pacientes con esta enfermedad tienen que tomar decisiones constantemente sobre las dosis de insulina que lleva a la glucosa a niveles seguros. Si no lo consiguen, pueden sufrir las complicaciones crónicas y agudas derivadas de los niveles anormalmente altos o bajos de glucosa. La regulación automática de glucosa con sistemas de páncreas artificial prometía reducir la carga del autocontrol de la enfermedad al mismo tiempo que se mejoraba el tiempo en normoglucemia y se reducía la variabilidad. Sin embargo, estas promesas sólo se han cumplido parcialmente. Aunque esta tecnología mejora el control glucémico que logran las terapias tradicionales, la ingesta de alimentos y la práctica de ejercicio limitan la eficiencia de los sistemas de páncreas artificial durante el día. De hecho, los sistemas comerciales sólo pueden hacerles frente con la ayuda de los pacientes. Para compensar las ingestas, los pacientes deben anunciar el contenido de carbohidratos al sistema. Para el ejercicio, deben anunciar el inicio de la actividad o tomar medidas preventivas como modificar la referencia de glucosa o reducir la basal con mucha antelación. Estas exigencias no sólo no ayudan a reducir la carga del paciente, sino que pueden comprometer la eficiencia del sistema cuando el paciente se equivoca al estimar los carbohidratos, omite el anuncio de la comida o no puede planificar el ejercicio. Así pues, esta tesis propone nuevos métodos para eliminar el anuncio de ingestas y ejercicio lo que ayudaría a reducir la intervención del paciente en los sistemas de páncreas artificial, y, en consecuencia, mejorar la calidad de vida. Desde un punto de vista de control, las ingestas y el ejercicio pueden considerarse perturbaciones. Esta tesis explota métodos de la literatura de rechazo de perturbaciones y acomodación de fallos para lograr el objetivo de la tesis. En concreto, hay que destacar tres aplicaciones: 1) se ha desarrollado un observador super-twisting para detectar comidas no anunciadas como primer paso para su compensación; 2) se ha diseñado un observador de modos deslizantes de primer orden para la estimación de la ratio de aparición de glucosa, la cual ha sido integrada en un generador de bolos para compensar las comidas; 3) se ha empleado el principio de diseño por modelo interno para mitigar el efecto de las ingestas de alimentos y ejercicio, añadiendo sugerencias de carbohidratos de rescate a la insulina. Como resultado, las contribuciones de esta tesis allanan el camino para el desarrollo de sistemas de páncreas artificial sin anuncios, que liberen al paciente de la carga de la gestión de la diabetes., [CA] Les infusions exògenes d'insulina són vitals per a les persones amb diabetis tipus 1 per a suplir parcialment l'incapacitat del pàncrees de secretar insulina. No obstant, les teràpies intensives actuals poden restringir la qualitat de vida dels pacients. Les persones amb aquesta malaltia han de prendre decisions contínuament sobre la dosi d'insulina que fa que la glucosa estiga en valors segurs. Si no ho aconsegueixen, poden sofrir les complicacions cròniques i agudes derivades dels nivells anormalment alts o baixos de glucosa. La regulació automàtica de glucosa amb sistemes de pàncrees artificials prometia reduir la càrrega d'autocontrol de la malaltia al mateix temps que es millorava el temps en normoglucèmia i es reduïa la variabilitat. No obstant, aquestes promeses s'han complit només parcialment. Encara que aquesta tecnologia millora el control de la glucosa, la ingesta d'aliments i la pràctica d'exercici limiten l'eficiència dels sistemes de pàncrees artificials durant el dia. De fet, els sistemes comercials només poden fer-les front amb la ajuda dels pacients. Per a compensar les ingestes, el pacients han d'anunciar al sistema la quantitat de carbohidrats. Per al exercici, han d'anunciar l'inici de l'activitat o prendre mesures preventives com modificar la referència de glucosa o reduir la infusió basal d'insulina. Aquestes exigències no només no ajuden a reduir la càrrega al pacient, sinó que poden comprometre l'eficiència del sistema quan el pacient confon la estimació dels carbohidrats, omet l'anunciament de la ingesta o no pot planificar l'exercici. Així doncs, aquesta tesi proposa nous mètodes per a eliminar l'anunciament d'ingestes i exercici permetent reduir així la intervenció del pacient, i, en conseqüència, millorar la qualitat de vida. Des del punt de vista de control, les ingestes i el exercici poden considerar-se pertorbacions. Aquesta tesi explota mètodes de la literatura de rebuig de pertorbacions i acomodament de fallades. En particular, es destaquen tres aplicacions: 1) s'ha desenvolupat un observador super-twisting per a detectar ingestes no anunciades com a primer pas per a la seua compensació; 2) se ha dissenyat un observador de modes lliscants per a estimar el rati d'aparició de glucosa de la ingesta, el qual s'ha integrat en un generador de bols d'insulina per compensar les ingestes; 3) se ha empleat el principi de disseny per model intern per a mitigar l'efecte de les ingestes i exercici, incorporant recomanacions de carbohidrats a la insulina. Com a resultat, les contribucions d'aquesta tesi obren el camí per a desenvolupar sistemes de pàncrees artificial sense anunciaments, que alliberen al pacient de la càrrega de la gestió de la diabetis., [EN] Exogenous insulin infusions are vital for people with type 1 diabetes to partially make up for the inability of the pancreas to secrete insulin. However, current intensive therapies may restrict patients' quality of life. People with this disease have to constantly make decisions about insulin doses to bring glucose levels to a safe range. If unsuccessful, they may suffer from chronic and acute complications related to abnormally high and low glucose values. The automatic regulation of glucose with artificial pancreas systems promised to reduce patients' self-control burdens while improving time in normoglycemia and decreasing variability. However, these promises are fulfilled only partially. Although this technology outperforms the glycemic outcomes achieved by conventional therapies, meal intake and physical activity limit its daytime performance. Indeed, commercially available systems only can handle them with the support of the patients. For meals, patients must announce the carbohydrate content to the system. For exercise, they must notify the activity or take preventive actions like changing glucose setpoint or decreasing basal well ahead before exercise. These demands do not help reduce the patient's burden. They even can compromise the system performance when the patient misestimates the carbohydrate content, omits the meal announcement, or cannot plan the exercise event. Hence, this thesis proposes new methods to eliminate the need for meal and exercise announcements, thus reducing patient intervention in artificial pancreas systems for a better quality of life. From a control perspective, meals and exercise can be regarded as disturbances; therefore, this thesis exploits methods from the disturbance rejection and fault accommodation literature to achieve the thesis goal. Specifically, the following three applications must be highlighted: 1) a super-twisting-based residual generator has been developed to detect unannounced meals as the first step to their compensations; 2) a sliding-mode disturbance observer has been designed to estimate the glucose meal appearance, which is fed into a bolusing algorithm to compensate the meals; 3) the internal model principle is employed to mitigate the effects of meal intakes and exercise, supplementing insulin infusions with carbohydrate recommendations. As a result, the contributions of this thesis pave the way for the development of announcement-free artificial pancreas systems, releasing patients from the burden of diabetes management., This work was partially supported by: grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033; and grant ACIF/2017/021 funded by the Generalitat Valenciana through European Social Funds (FSE). Also, the grant BEFPI/2019/077, funded by the Generalitat Valenciana through FSE funds, supported a 7-month research stay at Physiological da University (Óbudai Egyetem, Óbuda, Budapest, Hungary)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Impact of continuous moderate-intensity aerobic exercise on glycemic control according to different phases of the menstrual cycle in females with type 1 diabetes

  • Martín-San Agustín, Rodrigo
  • Cuerda del Pino, Alba
  • Laguna Sanz, Alejandro José
  • Rossetti, Paolo
  • Ampudia-Blasco, Francisco Javier
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Aim: To assess the effects of continuous moderate-intensity aerobic exercise (CONT) on glycemic control in women with type 1 diabetes (T1D) across different phases of the menstrual cycle. Methods: Twenty-five women with T1D completed two 30-minute CONT sessions: one during the follicular phase and the other during the luteal phase. Glycemic control was assessed during exercise by plasma glucose analysis and at 24 h post-exercise by continuous glucose monitoring. Results: A decline in blood glucose levels was observed after exercise, regardless of menstrual phase, from approximately 155 mg/dL to about 110 mg/dL. In the 24 h following exercise, the incidence of hypoglycemia was low (less than 2 %); in contrast, exercise in the luteal phase tended to increase hyperglycemia compared to the previous 24 h (from 38.2 % to 44.2 %), as well as compared to the follicular phase, with higher mean blood glucose levels observed. Conclusion: CONT has an immediate glucose-lowering effect regardless of menstrual cycle phase. However, while in the follicular phase TIR remains stable, in the luteal phase, it declines, with a corresponding increase in hyperglycemia, supporting the idea that exercise-induced glucose regulation varies across menstrual phases, highlighting the potential need for insulin dose adjustments depending on the cycle's phase., This work was supported by grant PID2019-107722RB-C21, funded by MCIN/AEI/10.13039/501100011033, as well as by CIBER-Consorcio Centro de Investigacion Biomedica en Red (Group Numbers CB17/08/00004 and CB07/08/0018), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, and the European Union-European Regional Development Fund (ERDF) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Safety and performance of a hybrid closed-loop insulin delivery system with carbohydrate suggestion in adults with type 1 diabetes prone to hypoglycemia

  • Mesa, Álex
  • Beneyto, Aleix
  • Viaplana, Judith
  • Vehí, Josep
  • Conget, Ignacio
  • Giménez, Marga
  • Martín-SanJosé, Juan-Fernando|||0000-0002-3247-6156
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Aims: To evaluate the safety and performance of a hybrid closed-loop (HCL) system with automatic carbohydrate suggestion in adults with type 1 diabetes (T1D) prone to hypoglycemia.Methods: A 32-hour in-hospital pilot study, including a night period, 4 meals and 2 vigorous unannounced 45minute aerobic sessions, was conducted in 11 adults with T1D prone to hypoglycemia. The primary outcome was the percentage of time in range 70-180 mg/dL (TIR). Main secondary outcomes were time below range < 70 mg/dL (TBR < 70) and < 54 (TBR < 54). Data are presented as median (10th-90th percentile ranges).Results: The participants, 6 (54.5%) men, were 24 (22-48) years old, and had 22 (9-32) years of T1D duration. All of them regularly used an insulin pump and a continuous glucose monitoring system. The median TIR was 78.7% (75.6-91.2): 92.7% (68.2-100.0) during exercise and recovery period, 79.3% (34.9-100.0) during postprandial period, and 95.4% (66.4-100.0) during overnight period. The TBR < 70 and TBR < 54 were 0.0% (0.0-6.6) and 0.0% (0.0-1.2), respectively. A total of 4 (3-9) 15-g carbohydrate suggestions were administered per person. No severe acute complications occurred during the study.Conclusions: The HCL system with automatic carbohydrate suggestion performed well and was safe in this population during challenging conditions in a hospital setting., This work has been funded by Instituto de Salud Carlos III (ISCIII) through the project "PI19/01865" and co-funded by the European Union. It was also partially supported by the Spanish Ministry of Science and Innovation through grants PID2019-107722RB-C21 and PID2019-107722RB-C22, and in part by the Spanish Ministry of Universities and by the European Union through Next GenerationEU (Margarita Salas). Finally, it was also partially funded by Hospital Clinic de Barcelona under "Contractes Clinic de Recerca Emili Letang-Josep Font" 2021.The authors thank the research participants for their time, insight and dedication; as well as the staff at Hostal Lleida and at the Diabetes unit and hospital food service at Hospital Clinic de Barcelona for invaluable help.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

In silico validation of a customizable fully-autonomous artificial pancreas with coordinated insulin, glucagon and rescue carbohydrates

  • Sanz Diaz, Ricardo
  • Sala-Mira, Iván|||0000-0002-6228-5190
  • Furió-Novejarque, Clara|||0000-0003-2923-6618
  • García Gil, Pedro José|||0000-0002-1202-1269
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Artificial pancreas systems should be designed considering different patient profiles, which is challenging from a control theory perspective. In this paper, a flexible-hybrid dual-hormone control algorithm for an artificial pancreas is proposed. The algorithm handles announced/unannounced meals by means of a noninteracting feedforward scheme that safely incorporates prandial boluses. Also, a coordination strategy is employed to distribute the counter-regulatory actions, which can be delivered as a continuous glucagon infusion via an automated pump, as an oral rescue carbohydrate recommendation, or as a rescue glucagon dose recommendation to be administrated through a glucagon pen. The different configurations of the proposed controller were evaluated in silico using a 14-day virtual scenario with random meal intakes and exercise sessions, achieving above 80% time-in-range and low time spent in hypoglycemia., This work was partially supported by the grants PID2019-10772 2RB-C21 funded by MCIN/AEI/10.13039/501100011033, CIPROM/2021/012 funded by Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital from Generalitat Valenciana, and FPU17/03404 funded by MCIN/AEI/10.13039/501100011033.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Probabilistic Model of Transition between Categories of Glucose Profiles in Patients with Type 1 Diabetes Using a Compositional Data Analysis Approach

  • Biagi, Lyvia
  • Bertachi, Arthur Hirata
  • Giménez, Marga
  • Conget, Ignacio
  • Bondia, Jorge
  • Martín Fernández, Josep Antoni
  • Vehí, Josep
The time spent in glucose ranges is a common metric in type 1 diabetes (T1D). As the time in one day is finite and limited, Compositional Data (CoDa) analysis is appropriate to deal with times spent in different glucose ranges in one day. This work proposes a CoDa approach applied to glucose profiles obtained from six T1D patients using continuous glucose monitor (CGM). Glucose profiles of 24-h and 6-h duration were categorized according to the relative interpretation of time spent in different glucose ranges, with the objective of presenting a probabilistic model of prediction of category of the next 6-h period based on the category of the previous 24-h period. A discriminant model for determining the category of the 24-h periods was obtained, achieving an average above 94% of correct classification. A probabilistic model of transition between the category of the past 24-h of glucose to the category of the future 6-h period was obtained. Results show that the approach based on CoDa is suitable for the categorization of glucose profiles giving rise to a new analysis tool. This tool could be very helpful for patients, to anticipate the occurrence of potential adverse events or undesirable variability and for physicians to assess patients’ outcomes and then tailor their therapies, This project has been partially supported by the Spanish Government, Ministerio de Economía y Competitividad (MINECO) (Grants DPI2016-78831-C2-1-R, DPI2016-78831-C2-2-R, RTI2018-095518-B-C21), Agencia Estatal de Investigación (PID2019-107722RB-C21/ AEI/10.13039/501100011033), the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7, 207688/2014-1 and EU through FEDER funds